Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$127.16
+3.3%
$128.93
$107.00
$160.29
$3.17B0.74274,009 shs141,496 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$15.95
-13.7%
$21.32
$9.98
$29.65
$1.09B1.641.92 million shs2.31 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+2.91%+3.25%+2.70%-20.17%-8.62%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+2.44%-5.38%+1.04%-3.65%-17.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$127.16
+3.3%
$128.93
$107.00
$160.29
$3.17B0.74274,009 shs141,496 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$15.95
-13.7%
$21.32
$9.98
$29.65
$1.09B1.641.92 million shs2.31 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+2.91%+3.25%+2.70%-20.17%-8.62%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+2.44%-5.38%+1.04%-3.65%-17.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$169.0032.91% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.55
Moderate Buy$30.1689.13% Upside

Current Analyst Ratings Breakdown

Latest ICUI and TNDM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Set Price Target$24.00
5/7/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
UpgradeStrong-Buy
4/27/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Lower Price TargetOverweight$180.00 ➝ $164.00
4/27/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
UpgradeHoldStrong-Buy
4/24/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Set Price Target$45.00
4/20/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Reiterated RatingBuy$25.00 ➝ $28.00
4/17/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Lower Price TargetOverweight$178.00 ➝ $163.00
4/9/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Lower Price TargetNeutral$28.00 ➝ $25.00
3/19/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
UpgradeHoldBuy$27.00 ➝ $35.00
3/17/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
UpgradeNeutralOverweight$21.00 ➝ $33.00
3/2/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Boost Price TargetEqual Weight$23.00 ➝ $25.00
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.23B1.42$15.51 per share8.20$86.03 per share1.48
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.01B1.08N/AN/A$2.29 per share6.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$730K$0.026,346.0717.001.720.03%7.33%3.72%N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$3.07N/AN/AN/A-20.17%-68.23%-11.07%N/A

Latest ICUI and TNDM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.46-$0.30+$0.16-$0.30$240.41 million$247.22 million
2/19/2026Q4 2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.68$1.91+$0.23-$0.64$541.20 million$535.94 million
2/19/2026Q4 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.05-$0.01+$0.04-$0.01$277.14 million$290.38 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.60
2.39
1.15
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.00
2.55
2.02

Institutional Ownership

CompanyInstitutional Ownership
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.10%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
13,00024.99 million24.47 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50068.50 million67.07 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$127.16 +4.09 (+3.32%)
As of 11:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$15.95 -2.52 (-13.67%)
As of 11:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.